NSC-70220 is a selective allosteric SOS1 inhibitor with anticancer activity; it inhibits allosteric site activation and partially suppresses catalytic site activation; it demonstrates synergistic growth inhibitory effects in combination with NSC-658497; it reduces the expression levels of P-AKT and P-ERK.